Skip to main content
NewslettersWatchlist

Medtronic Inc(MDT-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low79.99
Day High81.73
Open:79.99
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
TheNewswire.com
Cloud DX Reports Significant Revenue and Profit Growth in 2023
Newswire.ca
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Motley Fool
Medtronic Stock: Buy, Sell, or Hold?
Yolowire
The Value Unlocker: Why Ed Breen Makes Investors Money
Newswire.ca
Americans favor quality over quantity in pursuit of longevity
Motley Fool
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Motley Fool
Here Are My Top Artificial Intelligence (AI) Stocks to Buy Now
Newswire.ca
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
Newswire.ca
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
Newswire.ca
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
Newswire.ca
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Motley Fool
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
Motley Fool
2 Healthcare Artificial Intelligence (AI) Stocks That Could Be Smart Investment Bets
Motley Fool
The Smartest Dividend Stocks to Buy With $400 Right Now
Motley Fool
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
Barchart
Stocks Settle Higher on Lower Bond Yields and Quarter-End Window Dressing
Barchart
Tech Stocks Pressured by Nvidia
Barchart
Stocks Push Higher as T-note Yields Slip
GlobeNewswire
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
Newswire.ca
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
Motley Fool
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000

Profile

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.